Additionally, IL‐6 and IL‐8 have been associated with poorer overall survival in patients with GBM, whereas below‐median levels of transforming growth factor‐beta (TGF‐β) have been linked to increased survival. The gene discussed is IL6; the disease is glioblastoma.